Lv12
60 积分 2024-11-26 加入
Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications
32分钟前
已完结
NK cell and DC interactions
15小时前
已完结
Spontaneous Cell-Mediated Cytotoxicity in Humans: Role of Interferon and Immunoglobulins
16小时前
已完结
Brief Report: Preventing Infusion-related Reactions With Intravenous Amivantamab: Results From SKIPPirr, a Phase 2 Study
17小时前
已完结
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
19天前
已完结
Hematological toxicities in antibody–drug conjugates related with breast cancer: a pharmacovigilance study using FDA adverse event reporting system database
1个月前
已完结
皖公网安备34019202002308
